Medications development: Successes and challenges
- 31 October 2005
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 108 (1), 94-108
- https://doi.org/10.1016/j.pharmthera.2005.06.010
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- A pilot trial of topiramate for the treatment of cocaine dependenceDrug and Alcohol Dependence, 2004
- Treatment of Cocaine‐Alcohol Dependence with Naltrexone and Relapse Prevention TherapyThe American Journal on Addictions, 2004
- Buprenorphine and a CRF1 Antagonist Block the Acquisition of Opiate Withdrawal-Induced Conditioned Place Aversion in RatsNeuropsychopharmacology, 2004
- Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field ExperienceThe American Journal on Addictions, 2004
- Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and NaloxoneNew England Journal of Medicine, 2003
- Effects of D-cycloserine on extinction of conditioned freezing.Behavioral Neuroscience, 2003
- A POTENTIAL ROLE FOR GABAB AGONISTS IN THE TREATMENT OF PSYCHOSTIMULANT ADDICTIONAlcohol and Alcoholism, 2002
- Effects of buprenorphine and naloxone in morphine-stabilized opioid addictsDrug and Alcohol Dependence, 1998
- A controlled trial of imipramine for the treatment of methamphetamine dependenceJournal of Substance Abuse Treatment, 1996
- Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonistsJournal of Medicinal Chemistry, 1993